Doyle Mittie Insider Trades

Insider Trading History

Track insider trading activity for Doyle Mittie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $954k 51,776 shares
Last Trade
Jun 30, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$93.1k 4,654 shares
$20.00
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $1.04M 56,430 shares
Last Trade
Jun 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$86k 4,654 shares
$18.48
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $2.32M 125,750 shares
Last Trade
Jun 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$86k 4,654 shares
$18.48
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $2.15M 116,871 shares
Last Trade
Jun 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.9k 1,450 shares
$17.83
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $954k 51,776 shares
Last Trade
Jun 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.1k 1,450 shares
$18.00
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $980k 53,226 shares
Last Trade
Jun 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$25.9k 1,450 shares
$17.83
$18.42
Cullinan Therapeutics
Cullinan Therapeutics CGEM
Director
Holding Value $387k 21,781 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$295k 21,781 shares
$13.55
$17.77
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $954k 51,776 shares
Last Trade
Jun 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.2k 1,084 shares
$13.10
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $880k 47,801 shares
Last Trade
May 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11k 679 shares
$16.13
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $868k 47,122 shares
Last Trade
May 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.9k 679 shares
$16.00
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $2.18M 118,321 shares
Last Trade
May 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11k 679 shares
$16.13
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $868k 47,122 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$722k 43,500 shares
$16.60
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $66.7k 3,622 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$56.3k 3,000 shares
$18.76
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $122k 6,622 shares
Last Trade
May 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$53.2k 3,000 shares
$17.74
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $2.37M 128,625 shares
Last Trade
May 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$53.2k 3,000 shares
$17.74
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $2.03M 110,177 shares
Last Trade
May 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.32M 106,555 shares
$21.81
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $2.42M 131,625 shares
Last Trade
May 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.32M 106,555 shares
$21.81
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $1.52M 82,639 shares
Last Trade
May 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.2M 106,555 shares
$20.68
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $97.6k 5,301 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.3k 1,679 shares
$16.26
$18.42
Avalo Therapeutics
Avalo Therapeutics AVTX
Chief Medical Officer
Holding Value $3.86M 209,530 shares
Last Trade
May 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.3k 1,679 shares
$16.26
$18.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up